Octarine Bio Secures €12.8M Series A for Sustainable Pigment Revolution
January 25, 2026, 3:38 am
Octarine Bio, a Danish biotech innovator, secured an additional €5 million, pushing its total Series A funding to €12.8 million. This significant investment fuels the industrial scaling and commercial rollout of its PurePalette platform. PurePalette leverages precision fermentation to engineer sustainable natural pigments. These high-performance, bio-based dyes offer eco-friendly alternatives to fossil-based colorants. Initially targeting textiles, its applications will expand to food and cosmetics. This strategic capital injection drives a greener future for global coloration, promising reduced environmental impact and expanded market reach. The funding solidifies Octarine Bio's position at the forefront of sustainable materials innovation.
Octarine Bio has secured an additional €5 million in funding. This brings its total Series A financing to €12.8 million. This figure includes earlier pre-Series A capital. The Danish biotech firm pushes to scale its new platform. The focus is sustainable, bio-based pigments. This investment marks a significant milestone.
Based in Denmark, Octarine Bio uses precision fermentation. This method engineers microbial systems. These systems produce natural pigments. The pigments serve as high-performance alternatives. They replace fossil-based dyes. A key emphasis lies on integration. The technology fits existing textile manufacturing workflows. This ensures broad industry adoption.
The new capital targets critical expansion. It will accelerate industrial-scale validation. It funds the commercial rollout of PurePalette. This is Octarine Bio's natural pigment platform. PurePalette delivers the full color spectrum. It does so through a single production process. This offers unprecedented efficiency.
PurePalette positions itself as a fully bio-based color platform. It boasts impressive color strength. Its performance and stability are robust. It maintains a proven low environmental impact. Initial applications span textiles. Potential also exists in adjacent categories. These include food and beverage. Cosmetics are another key area. The funding supports scaling production of its first three flagship colors. It also enables the execution of commercial partnerships. Product development will expand into additional industries.
The Series A round saw strong backing. Existing investors provided continued support. New backers also joined. These include The Footprint Firm, Edaphon, and Unconventional Ventures. DSM-Firmenich Ventures and Oskare Capital also invested. A group of business angels contributed. Notable participants include Per Falholt and Steen Riisgaard. They are former CSO and CEO of Novozymes, now Novonesis. Their involvement underscores industry confidence.
Octarine Bio's leadership views this funding as pivotal. The Series A completion enables crucial scaling. It advances production of the initial PurePalette colors. It empowers the company to execute existing commercial partnerships. Expansion into new industries is now feasible. These new partners bring valuable industry-relevant capabilities.
Experts in the investment community recognize PurePalette's impact. One investor highlighted its potential. It can drastically reduce the environmental footprint. Textile dyeing is notoriously polluting. By seamlessly integrating into current dyeing processes, PurePalette can achieve widespread adoption. This drives meaningful change across the industry.
Founded in 2018, Octarine Bio operates in synthetic biology. The company engineers microbial systems. Its goal is producing bio-based pigments. These pigments exhibit a proven low environmental impact. Proprietary fermentation and biocatalysis platforms are central. Octarine Bio creates high-performance alternatives. These directly replace fossil-based dyes. They are designed for direct integration.
PurePalette claims a unique industry position. It is the only fully bio-based color platform. It delivers the entire color spectrum. This comes from a single production process. The platform offers high color strength. It ensures superior performance and stability. All this while maintaining a low environmental impact. These unique properties enable diverse applications. They range from textiles to food and beverage. Cosmetics and many other areas benefit.
Octarine Bio's success reflects a broader trend. European funding activity in synthetic biology is rising. Sustainable materials also attract significant capital. 2025 and 2026 show this pattern. Other companies in London and Helsinki have also secured funding. These focus on synthetic-biology-enabled textiles or protein engineering. This indicates sustained investment. It targets platform technologies. These support scalable biological production.
This funding flow is selective. It emphasizes European ventures. Octarine Bio's financing aligns with this trend. Investors see enormous potential. Bio-based color in textiles and other sectors is a vast opportunity. The team's expertise is world-class. This combination drives groundbreaking technology to market.
The global textile industry faces immense pressure. Sustainable practices are increasingly demanded. Traditional dyeing consumes excessive water. It releases harmful chemicals. Octarine Bio provides a direct solution. Its technology bypasses these environmental concerns. It offers a cleaner, greener alternative. This represents a fundamental shift.
This advancement has profound implications. It can reshape industrial supply chains. It reduces manufacturing footprints. Brands can more easily achieve sustainability goals. Consumers gain access to ethically produced goods. The environmental benefits are clear. Water usage is reduced. Chemical waste is minimized. Carbon emissions are lowered. All contribute to a healthier planet.
Integration into existing systems is crucial. This significantly lowers adoption barriers. Textile manufacturers avoid needing entirely new infrastructure. They can simply substitute conventional dyes. This practical approach accelerates market penetration. It makes the transition to sustainable pigments commercially viable.
Octarine Bio is building more than a product. It is creating a platform. PurePalette's versatility is a core strength. Its ability to deliver a full color spectrum is revolutionary. This eliminates the need for multiple dye types. It streamlines production processes. It reduces operational complexity. This unified approach offers both efficiency and consistency.
The future of sustainable biotech looks promising. Octarine Bio stands at the forefront of this movement. Its successful funding round validates its vision. It provides the necessary resources for widespread impact. Expect to see PurePalette colors in more consumer products. From apparel to food items, a vibrant revolution is underway. This marks a critical step towards a more sustainable global economy. The company is set to redefine color, using nature's own palette.
Octarine Bio has secured an additional €5 million in funding. This brings its total Series A financing to €12.8 million. This figure includes earlier pre-Series A capital. The Danish biotech firm pushes to scale its new platform. The focus is sustainable, bio-based pigments. This investment marks a significant milestone.
Based in Denmark, Octarine Bio uses precision fermentation. This method engineers microbial systems. These systems produce natural pigments. The pigments serve as high-performance alternatives. They replace fossil-based dyes. A key emphasis lies on integration. The technology fits existing textile manufacturing workflows. This ensures broad industry adoption.
The new capital targets critical expansion. It will accelerate industrial-scale validation. It funds the commercial rollout of PurePalette. This is Octarine Bio's natural pigment platform. PurePalette delivers the full color spectrum. It does so through a single production process. This offers unprecedented efficiency.
PurePalette positions itself as a fully bio-based color platform. It boasts impressive color strength. Its performance and stability are robust. It maintains a proven low environmental impact. Initial applications span textiles. Potential also exists in adjacent categories. These include food and beverage. Cosmetics are another key area. The funding supports scaling production of its first three flagship colors. It also enables the execution of commercial partnerships. Product development will expand into additional industries.
The Series A round saw strong backing. Existing investors provided continued support. New backers also joined. These include The Footprint Firm, Edaphon, and Unconventional Ventures. DSM-Firmenich Ventures and Oskare Capital also invested. A group of business angels contributed. Notable participants include Per Falholt and Steen Riisgaard. They are former CSO and CEO of Novozymes, now Novonesis. Their involvement underscores industry confidence.
Octarine Bio's leadership views this funding as pivotal. The Series A completion enables crucial scaling. It advances production of the initial PurePalette colors. It empowers the company to execute existing commercial partnerships. Expansion into new industries is now feasible. These new partners bring valuable industry-relevant capabilities.
Experts in the investment community recognize PurePalette's impact. One investor highlighted its potential. It can drastically reduce the environmental footprint. Textile dyeing is notoriously polluting. By seamlessly integrating into current dyeing processes, PurePalette can achieve widespread adoption. This drives meaningful change across the industry.
Founded in 2018, Octarine Bio operates in synthetic biology. The company engineers microbial systems. Its goal is producing bio-based pigments. These pigments exhibit a proven low environmental impact. Proprietary fermentation and biocatalysis platforms are central. Octarine Bio creates high-performance alternatives. These directly replace fossil-based dyes. They are designed for direct integration.
PurePalette claims a unique industry position. It is the only fully bio-based color platform. It delivers the entire color spectrum. This comes from a single production process. The platform offers high color strength. It ensures superior performance and stability. All this while maintaining a low environmental impact. These unique properties enable diverse applications. They range from textiles to food and beverage. Cosmetics and many other areas benefit.
Octarine Bio's success reflects a broader trend. European funding activity in synthetic biology is rising. Sustainable materials also attract significant capital. 2025 and 2026 show this pattern. Other companies in London and Helsinki have also secured funding. These focus on synthetic-biology-enabled textiles or protein engineering. This indicates sustained investment. It targets platform technologies. These support scalable biological production.
This funding flow is selective. It emphasizes European ventures. Octarine Bio's financing aligns with this trend. Investors see enormous potential. Bio-based color in textiles and other sectors is a vast opportunity. The team's expertise is world-class. This combination drives groundbreaking technology to market.
The global textile industry faces immense pressure. Sustainable practices are increasingly demanded. Traditional dyeing consumes excessive water. It releases harmful chemicals. Octarine Bio provides a direct solution. Its technology bypasses these environmental concerns. It offers a cleaner, greener alternative. This represents a fundamental shift.
This advancement has profound implications. It can reshape industrial supply chains. It reduces manufacturing footprints. Brands can more easily achieve sustainability goals. Consumers gain access to ethically produced goods. The environmental benefits are clear. Water usage is reduced. Chemical waste is minimized. Carbon emissions are lowered. All contribute to a healthier planet.
Integration into existing systems is crucial. This significantly lowers adoption barriers. Textile manufacturers avoid needing entirely new infrastructure. They can simply substitute conventional dyes. This practical approach accelerates market penetration. It makes the transition to sustainable pigments commercially viable.
Octarine Bio is building more than a product. It is creating a platform. PurePalette's versatility is a core strength. Its ability to deliver a full color spectrum is revolutionary. This eliminates the need for multiple dye types. It streamlines production processes. It reduces operational complexity. This unified approach offers both efficiency and consistency.
The future of sustainable biotech looks promising. Octarine Bio stands at the forefront of this movement. Its successful funding round validates its vision. It provides the necessary resources for widespread impact. Expect to see PurePalette colors in more consumer products. From apparel to food items, a vibrant revolution is underway. This marks a critical step towards a more sustainable global economy. The company is set to redefine color, using nature's own palette.